Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131480) titled 'Efficacy and safety of PBMS-RT(Pelvic Bone Marrow Sparing Radiotherapy) compared with conventional radiotherapy in patients with cervical cancer' on Sept. 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of China Medical University
Condition:
Cervical cancer
Intervention:
PBMS Group:Pelvic Bone Marrow Sparing Radiotherapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: PBMS Group:400;Control group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.h...